Neurocrine Biosciences

Our Company

Neurocrine Biosciences, Inc of San Diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs.

In the News
1/25/2012 Neurocrine Biosciences Announces The FDA Has Granted Fast Track Designation For VMAT2 Inhibitor NBI-98854
1/19/2012 Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock view all press releases


Webcast Webcast

Neurocrine frequently conducts webcasts and conference calls to provide presentations and company updates and progress on research and development activiites.

 view current webcasts 



New Data Our Corporation Presentation

This presentation provides an overview of our company pipeline, program process, and financial highlights.

/common/images/orangearrow.gif view the presentation



Stock Quote
Price Quote 8.78
Change 0.35
(20 minutes delayed)
 
Date
1/27/2012
Time
4:00 pm